Core Viewpoint - BenQ Hospital's stock has dropped over 8%, reaching a new low of 4.12 HKD, which is more than a 55% decline from its IPO price of 9.34 HKD, marking the worst debut performance for a new Hong Kong stock in 2023 [1] Financial Performance - The company reported revenues of 2.34 billion RMB, 2.69 billion RMB, 2.66 billion RMB, and 1.31 billion RMB for the years 2022, 2023, 2024, and the six months ending June 30, 2025, respectively [1] - Corresponding net profits for the same periods were 89.55 million RMB, 170 million RMB, 110 million RMB, and 48.7 million RMB [1] Market Reaction - The public offering of BenQ Hospital received a lukewarm response, with the Hong Kong public offering being subscribed only 6.28 times and the international placement subscribed 1.28 times, both significantly lower than recent popular IPOs [1] - Analysts noted that the company's price-to-earnings (PE) ratio during the IPO phase was 29.8 times, which is substantially higher than the average PE ratio of 16.7 times for the private hospital sector in Hong Kong, indicating that overpricing was a direct cause of the significant drop in share price [1]
港股异动 | 明基医院(02581)跌超8%创上市新低 较招股价已跌超55%